- Around 1300 registered delegates from 50+ countries participated
- MoUs and Investments of close to INR 1,000 Crores were announced at BioAsia 2016
- Around 1200 trade, partnership and deliberation meetings conducted at the event
- 25 Technical sessions were conducted over the 3 days
- 110+ Global industry leaders and academic stalwarts spoke at the event
The 3-day BioAsia 2016 concluded last week on a grand note, amidst many significant agreements and Memorandum of Understandings signed between government and national & international organizations, thought provoking discussions bringing together a large number of industry leaders and government officials (State/Center and international), startups, regulators and academic experts. The event witnessed the largest ever traction in the history of BioAsia from the pharma, Life Sciences, Biotech and Healthcare Industry.
Around 1300 delegates from 50+ countries participated in the three day event. BioAsia 2016 witnessed the announcement of MoUs and Investments of close to INR 1,000 Crores. Around 1200 trade, partnership and deliberation meetings were conducted and 25 technical sessions were hosted this year at BioAsia. The event saw insightful sessions from more than 110 global industry leaders and academic stalwarts. BioAsia 2016 further hosted a breakfast meeting with AmCham (American Chamber of Commerce in India) which focused on business opportunities in Telangana and enable them to set shop; Indo-Norwegian networking dinner and many more fruitful closed door discussions. BioAsia 2016 also hosted a trade exhibition, CEO Conclave on Make in India and a Startup Showcase program.
Speaking on this occasion, Mr. Shakthi Nagappan, CEO of BioAsia said, “This edition of BioAsia has been intrumental in bringing together the stakeholders of Biotech, Healthcare, Pharma and IT industry. Partnerships like Ferring Pharma and Telangana Government made this year’s BioAsia a huge success. Around 1,300 delegates attended BioAsia 2016 during these 3 days representing 50+ countries. The networking meetings, breakfast deliberations and other 1-1 discussions will surely be the beginning for many more national and International business opportunities. We are happy to note that this year’s BioAsia has concluded on a grand note and we hope to come back with an even bigger and better platform in 2017.”
The last day of the event started with the Keynote session of Prof. Hilary Thomas, Chief Medical Advisor, KPMG and National Health Service, UK and Dr. Rajendra Pratap Gupta, Chairman India & India Representative, Personal Connected Health Alliance, India; who spoke about transforming healthcare through digitization. Day 3 witnessed participation of medical practitioners, IT experts and technologists for the Digital Health & Healthcare-IT Conference which was organized on the topics – 3D Printing, How pharma & biotech companies are using, technology to drive innovations, growth and productivity, Internet of Things and Big Data.
The eminent dignitaries who shared their insightful thoughts with the audience included Mr. Michel Pettigrew, President and COO, Ferring Pharma, Prof. Lee Cronin FRSE, FRSC Regius Chair of Chemistry, School of Chemistry, University of Glasgow, Mr. Subramanyam Guttina, Senior Lead Consultant, Watson Cognitive Computing for Healthcare and Life Sciences, IBM India Private Limited, and Dr Sai Praveen Haranath, American Board Certified in Internal Medicine, Apollo Hospitals.
Read more on BioAsia here.